FREENOME HOLDINGS INC.

In News

Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform - PR Newswire

PR Newswire - Dec 05, 2025

Cancer blood test maker Freenome going public with $330M SPAC - BioWorld MedTech

BioWorld MedTech - Dec 05, 2025

Perceptive Capital reports $240M PIPE and Freenome milestones (NASDAQ: PCSC) - Stock Titan

Stock Titan - Mar 02, 2026

Freenome to go public via SPAC deal with $240 million PIPE investment By Investing.com - Investing.com

Investing.com - Dec 05, 2025

Peninsula company rides blank check to Wall Street after raising more than $1 billion as a startup - The Business Journals

The Business Journals - Dec 08, 2025

Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer to Drive Commercial Strategy, As Agreement with Exact Sciences Clears Antitrust Review - PR Newswire

PR Newswire - Nov 10, 2025

Freenome And Perceptive Capital Merging In $330 Million SPAC Deal Backed By $240 Million PIPE - Pulse 2.0

Pulse 2.0 - Dec 07, 2025

Cancer Detection Biz Going Public Via $1.1B SPAC Merger - Law360

Law360 - Dec 05, 2025

Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection - PR Newswire

PR Newswire - Jan 12, 2026

Freenome's new CEO is ready to compete in race for tests that can detect cancer early - The Business Journals

The Business Journals - Jul 21, 2025

Freenome lands global commercialization deal with Roche for blood-based colon cancer test - The Business Journals

The Business Journals - Nov 18, 2025

Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S. - PR Newswire

PR Newswire - Nov 18, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment